Last updated: 11/04/2018 10:25:16

Clinical efficacy of a toothpaste in providing relief from the pain of dentinal hypersensitivity

GSK study ID
RH01324
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Completed
Completed
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: A clinical study investigating the efficacy of a dentifrice in providing short term relief from dentinal hypersensitivity
Trial description: A study to compare the efficacy of a test dentifrice against a control dentifrice in reducing dentinal hypersensitivity over a two week treatment period.
Primary purpose:
Treatment
Trial design:
Parallel Assignment
Masking:
Single (Investigator)
Allocation:
Randomized
Primary outcomes:

Change from Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale at Day 14

Timeframe: Baseline to Day 14

Secondary outcomes:

Change from Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale immediately post-treatment

Timeframe: Baseline to immediately post treatment administration

Change from Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale at Day 3

Timeframe: Baseline to Day 3

Change from Baseline in Tactile Pain Threshold Score at Day 14

Timeframe: Baseline to Day 14

Change from Baseline in Tactile Pain Threshold Score at Day 3

Timeframe: Baseline to Day 3

Change from Baseline in Tactile Pain Threshold Score immediately post-treatment

Timeframe: Baseline to immediately post treatment administration

Interventions:
Drug: Stannous Fluoride
Drug: Sodium Monofluorophosphate
Enrollment:
113
Observational study model:
Not applicable
Primary completion date:
2012-31-05
Time perspective:
Not applicable
Clinical publications:
Not applicable
Medical condition
Dentine Hypersensitivity
Product
sodium monofluorophosphate, stannous fluoride
Collaborators
Not applicable
Study date(s)
April 2012 to May 2012
Type
Interventional
Phase
3

Participation criteria

Sex
Female & Male
Age
18 - 65 years
Accepts healthy volunteers
Yes
  • Subjects who suffer from tooth sensitivity.

Trial location(s)

Location
Status
Contact us
Contact us
Location
BioSci Research America, Inc.
Las Vegas, NV, United States, 89121
Status
Recruiting

Study documents

Scientific result summary
Available language(s): English

If you wish to request for full study report, please contact - [email protected]

Results overview

Results posted on ClinicalTrials.gov

Recruitment status
Completed
Actual primary completion date
2012-31-05
Actual study completion date
2012-31-05

Plain language summaries

Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.

Additional information about the trial

Additional information
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website